background: Congenital bilateral absence of the vas deferens (CBAVD) is a distinct clinical entity accounting for 25% of obstructive azoospermia in infertile men. The association between CBAVD and mutated CFTR (cystic fibrosis transmembrane conductance regulator) alleles is well demonstrated in Caucasians, but the identity of CBAVD-susceptibility genes remains elusive in Asians. We investigate genomic copy number variations (CNVs) in a patient cohort of Taiwan.
Introduction
Congenital bilateral absence of the vas deferens (CBAVD) is a distinct clinical entity affecting 1 -2% of infertile men (Holsclaw et al., 1971) and is the most common cause of obstructive azoospermia in patients who have not undergone elective sterilization (Jarow et al., 1989) . This reproductive tract disorder also occurs in a mild form of cystic fibrosis (CF) (Holsclaw et al., 1971; de la Taille et al., 1998) . CF, a progressive lung disease that is characterized by mutations of the CF transmembrane conductance regulator (CFTR) gene (Riordan et al., 1989) , accounts for the most common autosomal recessive disorder in Caucasians. In the last decade, the linkage between the phenotypic and genotypic abnormalities of CBAVD has been investigated using various mutation detection methods. The results showed that the CFTR gene carries genetic variations in 50-74% of the alleles tested (Patrizio and Zielenski, 1996; de Meeus et al., 1998; Claustres et al., 2000; Josserand et al., 2001; Wang et al., 2002; Dayangaç et al., 2004) . However, the involvement of the CFTR gene in this infertility disorder is not observed in Asian populations (Welsh et al., 2001; Wong et al., 2003) . A recent survey of the mutation spectrum of the CFTR gene among 36 Taiwanese infertile men with CBAVD was performed using temporal temperature gradient gel electrophoresis mutational analysis. The results showed that the number of mutations was limited that the most common mutation IVS8-5T accounted for 81% of the mutations identified, and that the most mutant alleles (64%) remained unknown (Wu et al., 2005) , leaving the causes for the majority of affected Taiwanese individuals unknown. Based on these previous reports, we postulated that the underlying cause of Taiwanese CBAVD may be distinct from those of Europeans.
Microarray-based comparative genomic hybridization (array-CGH) is a high-throughput genomic analysis technology that enables efficient screening for copy number variations (CNVs). This technology is well documented in cancer research to identify amplicons and genome instability related to carcinogenesis (Yao et al., 2006; Lai et al., 2007) . Additionally, array-CGH is also suitable for the analysis of DNA number aberrations that cause human genetic disorders. Several studies using array-CGH have detected subtle genomic CNVs for 15q21 syndrome (Pramparo et al., 2005) , X-linked hypopituitarism (Solomon et al., 2004) , X-linked mental retardation (Bauters et al., 2005) and language disorder (Murthy et al., 2007) . In the present study, we employed a commercially available oligonucleotide arraybased CGH (Brennan et al., 2004) for genome-wide mapping of CNVs in Taiwanese men with CBAVD, followed by PCR analysis. All the patients had been diagnosed with CBAVD based on physical examination of the scrotal contents, followed by semen analysis and transrectal ultrasound for providing further evidence for confirmation. In addition, impaired sperm production and testis failure were ruled out as causes of infertility by examining spermatogenesis markers (serum FSH, LH, Testosterone and Prolactin levels) prior to sperm retrieval.
Materials and Methods

Control individuals
To obtain genomic DNA for use as a reference, healthy Taiwanese men were recruited to contribute DNA samples. Since several hereditary diseases do not affect carriers until adulthood, we set the age criteria of the normal controls to 30 to rule out subjects who look 'healthy' but have genetic defects. We also excluded individuals with diabetes mellitus, major systemic disorders, psychiatric disorders or neurological disorders (such as epilepsy), mental retardation, facial dysmorphysm and clinical evidence of brain, trunk or limb anomalies, from the control recruitment since people affected by these disorders may carry genetic defects.
After giving informed consent, 10 participants underwent screening interviews followed by the withdrawal of blood samples for DNA extraction and analyses. The reference DNA pool was obtained by pooling equal amounts of chromosomal DNA extracted from the lymphocytes of the 10 healthy men. Reference samples for array-CGH analysis were taken from this normal DNA pool.
Assessment and recruitment of CBAVD patients
Men with infertility were referred to us for diagnosis at Taipei Medical University Hospital in Taipei, Taiwan. The diagnosis of CBAVD was based on physical examination of the scrotal contents; men with the absence of palpable vas deferens on both sides, but with normal testes size (long axis .2 cm) were selected for further screening. Clinical examinations for CF symptoms did not identify any classic CF symptoms in any of the patients. Every patient provided detailed clinical and family histories. In addition to routine semen analysis, special examination for semen pH and fructose content was performed to confirm the CBAVD diagnosis. A total of 26 patients, V1 -V26, underwent transrectal ultrasonography for the evaluation of morphology and size of the seminal vesicles, prostate and ejaculatory ducts. We also performed renal ultrasonography to assess the existence and outlines of both kidneys and hormonal assays and chromosomal analyses to rule out testicular azoospermia.
After informed consent was obtained from each participant, blood samples were withdrawn and genomic DNA was extracted for analysis.
Genomic DNA extraction
Genomic DNA was prepared from peripheral blood lymphocytes using the Puregene DNA Purification Kit (Gentra Systems, Minneapolis, MN, USA) according to the manufacturer's instructions.
Array-based CGH analysis
A microarray containing over 44 000 oligonucleotides probes designed to cover coding, non-coding and intergenic sequences in the human genome (human genome CGH microarray 44B, Agilent Technologies, Palo Alto, CA, USA) was used for array-CGH analysis. Genomic DNA fragmentation, labelling and array hybridization were performed according to the standard array-CGH protocol (version 3) provided by Agilent Technologies as previously described (Lee et al., 2008) . To rule out probable normal copy number polymorphisms (CNPs) (Sebat et al., 2004) , which are more likely related to ethnicity, array hybridization experiment was performed with DNA pools from the healthy Taiwanese men and from healthy Caucasian men (Promega, Madison, WI, USA).
The hybridized arrays were scanned using a G2565B DNA microarray scanner (Agilent Technologies), and the microarray images were analyzed using FEATURE EXTRACTION software (version 8.1.1, Agilent Technologies) as previously described (Lee et al., 2008) .
Tiling path CGH arrays analysis
We performed tiling path array analysis using an Agilent system custom oligonucleotide Chromosome 3 array (HG18; NCBI build 36) covering 0. 068948-199.324720 Mb designed under the following specifications: isothermal probe (45-60 bp) with target T m of 85 and average interval spacing of 14.17 kb. Reference and test sample genomic DNA (250 ng each) was fluorescently labelled using the Agilent ULS Genomic DNA Labelling Kit (Agilent Technologies). For this study, each control DNA sample and CBAVD patient DNA sample was used as an independent test sample against a commercial reference DNA pool of Caucasian men (Promega). All hybridization and array scanning were performed as previously described (Lee et al., 2008) .
Quantitative real-time PCR
The fold change of PANK2 gene copy numbers were determined by realtime PCR using the LightCycler FastStart DNA Master PLUS SYBR Green I kit (Roche Molecular Systems, Inc., Branchburg, NJ, USA) and the LightCycler Instrument 1.5 (Roche Molecular Systems). Quantification was performed by comparing the target locus to the reference ACTB (encoding beta-actin). The relative PANK2 copy number level was normalized to normal control genomic DNA as calibrator. The change in copy number of the PANK2 gene relative to the ACTB and the calibrator were determined by using the formula (PANK2 CBAVD /ACTB CBAVD )/ (PANK2 control /ACTB control ) as described previously (Sasaki et al., 2007) , where PANK2 CBAVD and ACTB CBAVD are the quantity from the CBAVD sample. The cycling conditions were as follows: pre-incubation at 958C for 10 min, 40 cycles of 958C for 10 s, 608C for 15 s and 728C for 10 s. The specific oligonucleotide primer pairs were selected from the Universal Probe Library (Roche Molecular Systems), and the specificity of each primer pair was verified. The primers were
The mean threshold cycle number (C t ) for each gene in each sample was obtained from triplicate experiments.
Assay for homologous loss of PANK2
The presence of PANK2 allele was determined using PCR followed by electrophoresis. Heterozygous and homozygous losses of PANK2 were readily distinguishable by the presence of 215 bp amplified fragment. PCR was carried out using 10 ng genomic DNA as a template in a 50 ml reaction mixture containing 1.25 U of Tag DNA polymerase (Roche Molecular Systems), 250 mM dNTPs, 10 pmol of each sense (5 0 -gagaccctgtctccg ttttt-3 0 ) and antisense (5 0 -gtgcctgaagataccccaaa-3 0 ) primer and PCR buffer (10 mM Tris -HCl, 1.5 mM MgCl 2 , 50 mM KCl pH 8.3). Details of PCR conditions were as follows: initial denaturation at 958C for 10 min was followed by 35 cycles of 948C for 45 s, 588C for 45 s and 728C for 45 s and ended by an extension at 728C for 7 min. The GAPDH gene used for internal control was amplified under the same PCR conditions with primers (sense: 5 0 -cctgccaaatattgatgacatcaag-3 0 ; antisense: 5 0 -accctgttgctgtagccaaa-3 0 ). Amplified products were electrophoresed on a 3% agarose gel. The absence of a specific amplified fragment was interpreted as homozygous loss of PANK2.
Results
From a total of eight Taiwanese men affected with CBAVD, genomic DNA derived from peripheral lymphocytes was extracted and subjected to genome-wide array-CGH analysis using a commercially available oligonucleotide array that offers an average resolution of approximately of 35 kb. A total of 66 CNVs with high aberrant scores (,21 or .1) were found: 36 CNVs were assigned to known genes, 13 CNVs were assigned to intergenic regions and 17 were assigned to anonymous genes (function unknown). To filter out of the CNVs that are more likely to be related to ethnicity, the five CNPs were identified from the reference array which was performed with a normal male DNA pool in our laboratory (as described in Materials and Methods). Thus, PXT1 (6p21.31, STEPP), RAB11FIP3 (16p13.3, KIAA0665, Rab11-FIP3, eferin), SOLH (16p13.3, CAPN15), CRYAA (21q22.3, HSPB4) and C21orf57 (21q22.3) were excluded from subsequent data analysis. Additionally, the CNVs that have been reported among healthy controls on the Database of Genomic Variants (http://projects.tcag.ca/variation) website (Iafrate et al., 2004; Redon et al., 2006; Wong et al., 2007) were also excluded. Finally, five out the 14 remaining CNVs for known genes were referred to as reproduction-related, according to an online search for the relevant literature on PubMed (http://www.ncbi.nlm.nih.gov) using the keyword 'reproduction'. The five reproduction-related genes identified were PBX1 (Schnabel et al., 2003) , BRD3 (Boyer et al., 2004; Shang et al., 2004) , PANK2 (Kuo et al., 2005 (Kuo et al., , 2007 , COL18A1 (Nasu et al., 2003) and HMOX1 (Ozawa et al., 2002; Watanabe et al., 2004; Shiraishi et al., 2005) , which mapped to 1q23.3, 9q34.2, 20p13, 21q22.3 and 22q12.3, respectively (Table I) . PANK2 was the only reproductionrelated gene deleted in two CBAVD patients (V3 and V8) of this small study. There was no reproduction-related gene affected in Patients V1, V4 and V7. The detailed information on CNVs of reproduction-irrelevant or anonymous genes in these eight patients is provided in Table II . In Table III , we also summarized the intergenic sequences that showed CNVs. We noted that the genomic imbalance involving intergenic sequences located on chromosome 3 around 163.997 Mb (HG18) is prevalent (five of eight) in the CBAVD patients analyzed. The representative array results for PANK2 deletion and 3q26.1 microdeletion are shown in Fig. 1A and B, respectively.
All of the five reproduction-related genes were selected for qPCR analysis, but only the copy numbers of PANK2 were cross-validated in all samples (V1-V8), as shown in the Fig. 2 . Thus, we choose this reproduction-related gene for further investigation. To evaluate the association of copy number loss in PANK2 with CBAVD, we recruited another 11 subjects with CBAVD, Patients V9-V19, for quantitative PCR assessment. According to the interpretation of normalized gene dosage ratios described in Fig. 2 , PANK2 seemed to be affected by homozygous loss in three patients V3, V8 and V16, while variations were not observed in 10 healthy controls analysed.
To examine whether the losses of PANK2 are homozygous or heterozygous in affected individuals and to ascertain the association with CBAVD, we performed PCR followed by electrophoresis in 16 normal controls and 26 CBAVD subjects (V1 -V26). In addition, we also recruited 20 azoospermia patients without CBAVD with an intent to examine whether PANK2 is involved in spermatogenesis or in the development of the vas deferens. Homozygous deletion of PANK2 was detected in only one of the 26 (3.85%) CBAVD patients, whereas no deletions were detected in any cases of control individuals or azoospermic patients tested (Fig. 3) .
To better map the deletion breakpoints of 3q26.1 in CBAVD and assess the frequency of this microdeletion among unaffected individuals, we investigate seven of the original CBAVD subjects (V2 -V8) and eight control subjects using a chromosome 3 tiling path microarray comprised of 15 000 oligonucleotide probes. All patients with this microdeletion, V3, V4, V6, V7 and V8 were validated. However, we also identified seven controls deleted for 3q26.1, giving a frequency of 87.5% (Fig. 4) , which suggests that the 3q26.1 microdeletion may not be pathogenic. In this analysis, we characterized this microdeletion to 104 kb ranging from 163.997227 to 164.101835 Mb on chromosome 3, and containing sequences coding for the hypothetical protein, LOC647107.
Discussion
In this study, we have performed a genome-wide examination of genetic copy number aberrations in eight CBAVD patients. Array-CGH analysis identified five reproduction-related genes: PBX, BRD3, PANK2, COL18A1 and HMOX1. All showed a single incidence, except PANK2 which was affected in two patients. Subsequent qPCR Array-CGH analysis on CBAVD in Asian populations analysis for the five reproduction-related genes showed only deletion of PANK2 was cross-validated in all cases and was thus selected for further study. We employed performed deletion analysis by PCR in a larger cohort, including 26 CBAVD patients, 20 azoospermic patients without CBAVD and 16 healthy control men. Homozygous loss of PANK2 was detected in only one CBAVD patient (3.8%), while no loss was found in azoospermic and control subjects. Thus, the PANK2 gene has the potential to explain only a small percentage of this disorder, suggesting that other genetic factors must play a role. Furthermore, this study showed that the submicroscopic region The number indicates the score of CNVs for the eight CBAVD individuals (V1 -V8): no change is defined by n ¼ 0, high score loss is defined by n , 21 and high score gain is defined by n . 1. PBX1 (pre-B-cell leukaemia transcription factor 1), BRD3 (bromodomain containing 3), PANK2 (pantothenate kinase 2), COL18A1 (collagen, type XVIII, alpha 1) and HMOX1 (heme oxygenase 1). Their score of copy number alteration in the eight individuals (V) is displayed by a numbered grade of alteration (n) as described for Their score for copy number alteration in the eight individuals is displayed by a number as described in Table I . Array-CGH analysis on CBAVD in Asian populations located on 3q26.1 which was frequently deleted in CBAVD patients, was also deleted in control subjects, suggesting that this microdeletion is a CNP among Asian men and is not disease-causing. The PANK2 gene encodes pantothenate kinase 2 (Pank). Pantothenate kinase is the first enzyme in the biosynthetic pathway of co-enzyme A (CoA), catalyzing the ATP-dependent phosphorylation of pantothenate. As a ubiquitous metabolic substrate, CoA plays a critical role in the tricarboxylic acid cycle, in the synthesis of some amino acids and in the fatty acid metabolism. One isoform of Pank in mammals, Pank2 is probably uniquely located on mitochondria (Hö rtnagel et al., 2003; Johnson et al., 2004) , strongly implying its involvement in energy metabolism. Previous studies of human Pank2 (hPank2) have been mostly limited to the central nervous system, because a defect in this gene can give rise to a devastating neurodegenerative disorder named pantothenate kinase-associated neurodegeneration (PKAN, also known as Hallervorden-Spatz syndrome), which is mainly caused by a deficiency of CoA (Zhou et al., 2001; Hayflick et al., 2003a,b) . The novel role of Pank2 in reproduction was discovered in knock-out mice with homozygous loss of the orthologous murine gene, mPank2. The homozygous male mutants are azoospermic due to an arrest in spermiogenesis, which leads to complete absence of elongated and mature spermatids (Kuo et al., 2005 (Kuo et al., , 2007 . Contrary to the conditions observed in the infertile knock-out mice, all cases of CBAVD patients we analyzed were diagnosed without defects in spermiogenesis. Similarly, azoospermia had not been reported for men with PKAN. Here, rise two interesting questions: (i) Is the discrepancy due to a difference in spermiogenesis between human and mouse? (ii) Does the gene product of PANK2 play a different pathological role in human and mouse? A recent study carried out by Leonardi et al. (2007) supported the above speculations by showing that although the enzymatic properties of hPank2 and mPank2 are indistinguishable, there are obvious differences in gene structure, protein localization and relative abundance of protein in human and murine tissues. Interestingly, they found that PANK2 transcripts were low in mouse brain and were extremely high in mouse testis, whereas hPank2 were highest in the human brain but were considerably less abundant in human testis. What is the role of PANK2 in human reproduction and how might the homozygous deletion lead to CBAVD? To assist in addressing these questions, a study of the association between PANK2 and CBAVD with a higher sample size would be required, and detailed analysis of the expression patterns of PANK2 during wolffian duct development (Hannema et al., 2007) would also be signified. The fold change in gene copy number for the target gene (PANK2) relative to the endogenous reference gene (ACTB) was compared for the CBAVD samples (V1-V19) and the controls (N1-N10) as described in Materials and Methods. The fold change for PANK2 and ACTB of the control sample is set at 1. The normalized fold changes were interpreted as follows: no change (0.7 -1.4, white bar), homozygous loss (,0.3, black bar), over representation (.1.4, black bar) and ambiguous (0.3-0.7, gray bar). Agarose gel electrophoresis picture of the PCR products of PANK2 and GAPDH were shown for all cases of CBAVD (V1-V26), representative cases of azoospermia patients without CBAVD (A1-A10) and healthy controls (N1-N10). M, DNA marker. The absence of the specific amplified fragment of 215 bp was interpreted as homozygous loss of PANK2.
In conclusion, we have attempted to contribute to the discovery of causative CNVs, which are important to understand the pathogenesis of CBAVD in Asian populations. However, the incidence for potentially susceptible loci mapping to known genes was rare in our patient cohort, and the highly recurrent microdeletion on 3q26.1 seems not be pathogenic. Our exploratory data provide information on CNVs for CBAVD in Asian populations and suggest that other genetic events, including inversion, translocation, promoter mutations and even submicroscopic CNVs may be implicated in this form of male infertility. Several follow-up analyses are needed to assess the reproduction-related gene disrupted by CNV identified by this pilot study.
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